Screener
GT Biopharma GTBP Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$0.12Miss by $0.04
EPS estimate-$0.08
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$2.50
Versus estimates
Diluted EPS
FAQ
- When did GT Biopharma report Q2 2026 earnings?
- GT Biopharma (GTBP) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were GT Biopharma's Q2 2026 revenue and EPS?
- GT Biopharma reported eps of $-0.12 for Q2 2026.
- Did GT Biopharma beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.08 by $0.04.
- How did GT Biopharma's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 78.2% from $-0.55.
- Where can I find GT Biopharma's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001493152-26-038446) and the 10-Q periodic report (0001493152-26-037988) directly on SEC EDGAR. The filing index links above go to sec.gov.
